日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Erratum: Preliminary study of the mechanism of isolinderalactone inhibiting the malignant behavior of bladder cancer: Erratum

勘误:异立德内酯抑制膀胱癌恶性行为机制的初步研究:勘误

Wang, Qun; Xu, Wenkai; Ying, Lu; Shi, Hongjin; Sun, Yuxin; Feng, Wei; Xu, Haole; Xie, Jun; Wei, Hairong; Yang, Zhao; Wang, Haifeng

Preliminary study of the mechanism of isolinderalactone inhibiting the malignant behavior of bladder cancer.

异立德内酯抑制膀胱癌恶性行为机制的初步研究

Wang Qun, Xu Wenkai, Ying Lu, Shi Hongjin, Sun Yuxin, Feng Wei, Xu Haole, Xie Jun, Wei Hairong, Yang Zhao, Wang Haifeng

Postoperative adrenal cortical insufficiency following adrenal adenoma removal: a case report

肾上腺腺瘤切除术后肾上腺皮质功能不全:病例报告

Duan, Nanjun; Yang, Haidong; Luo, Jing; Yang, Wenli; Wang, Haifeng; Zhang, Weiran; Xu, Haole

Primary bladder diffuse large B-cell lymphoma: A rare case report

原发性膀胱弥漫性大B细胞淋巴瘤:一例罕见病例报告

Xu, Haole; Feng, Wei; Shi, Hongjin; Wang, Haifeng

A commentary on 'The role of cytoreductive nephrectomy in metastatic renal cell carcinoma in the targeted therapy and immunological therapy era: a systematic review and meta-analysis' [Int J Surg (2023) 109:982-994]

对“靶向治疗和免疫治疗时代转移性肾细胞癌中细胞减灭性肾切除术的作用:系统评价和荟萃分析”的评论[Int J Surg (2023) 109:982-994]

Wang, Qun; Shi, Hongjing; Sun, Yuxin; Feng, Wei; Xu, Haole; Wang, Haifeng

Development of a stemness-related prognostic index to provide therapeutic strategies for bladder cancer.

开发与干细胞特性相关的预后指数,为膀胱癌的治疗策略提供依据

Fu Shi, Tan Zhiyong, Shi Hongjin, Chen Junhao, Zhang Yawei, Guo Chunming, Feng Wei, Xu Haole, Wang Jiansong, Wang Haifeng

Unilateral adrenal Castleman's disease: A case report

单侧肾上腺卡斯尔曼病:病例报告

Li, Ji; Bai, Jing; Wang, Haifeng; Xu, Haole

Renal cancer combined with prostate cancer with ureteral metastasis: A case report

肾癌合并前列腺癌并伴输尿管转移:病例报告

Chen, Bo; Wang, Haifeng; Xu, Haole; Shi, Hongjin; Zuo, Yigang; Chen, Junhao; Feng, Wei; Li, Zhaojiao